Total Payments
$679.53
2024 Payments
$29.30
Companies
11
Transactions
19
Medicare Patients
229
Medicare Billing
$17,647
Payment Breakdown by Category
Food & Beverage$433.63 (63.8%)
Other$150.00 (22.1%)
Education$95.90 (14.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $433.63 | 16 | 63.8% |
| Honoraria | $150.00 | 1 | 22.1% |
| Education | $95.90 | 2 | 14.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $251.45 | 2 | $0 (2019) |
| ABBVIE INC. | $130.84 | 2 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $111.41 | 2 | $0 (2021) |
| Astellas Pharma US Inc | $51.72 | 4 | $0 (2021) |
| PFIZER INC. | $33.81 | 3 | $0 (2019) |
| Medtronic, Inc. | $29.30 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $15.24 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $15.21 | 1 | $0 (2019) |
| Allergan, Inc. | $14.92 | 1 | $0 (2020) |
| Genentech USA, Inc. | $13.07 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.30 | 1 | Medtronic, Inc. ($29.30) |
| 2023 | $114.57 | 1 | ABBVIE INC. ($114.57) |
| 2022 | $28.83 | 2 | ABBVIE INC. ($16.27) |
| 2021 | $78.13 | 5 | Astellas Pharma US Inc ($51.72) |
| 2020 | $14.92 | 1 | Allergan, Inc. ($14.92) |
| 2019 | $203.36 | 5 | Alexion Pharmaceuticals, Inc. ($150.00) |
| 2018 | $85.00 | 1 | Pharmacyclics LLC, An AbbVie Company ($85.00) |
| 2017 | $125.42 | 3 | Alexion Pharmaceuticals, Inc. ($101.45) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Drug Infusion Systems | ||||||
| 02/02/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $114.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/29/2021 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2021 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 01/05/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: ONCOLOGY | ||||||
| 05/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.24 | General |
| 09/11/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 07/29/2019 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), Erleada | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Oncology | ||||||
| 06/15/2019 | PFIZER INC. | XALKORI (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 11/14/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $101.45 | General |
| Category: Immunology | ||||||
| 09/27/2017 | PFIZER INC. | BESPONSA (Drug) | Education | In-kind items and services | $10.90 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2017 | Genentech USA, Inc. | GAZYVA (Biological), Rituxan | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 90 | $18,981 | $4,297 |
| 2022 | 4 | 84 | 116 | $27,570 | $6,817 |
| 2021 | 4 | 70 | 86 | $22,329 | $5,204 |
| 2020 | 1 | 15 | 22 | $3,353 | $1,329 |
Total Patients
229
Total Services
314
Medicare Billing
$17,647
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 41 | $11,070 | $2,445 | 22.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 29 | $4,930 | $1,219 | 24.7% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Facility | 2023 | 20 | 20 | $2,981 | $632.72 | 21.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 53 | $13,046 | $3,290 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 24 | $8,533 | $2,238 | 26.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 26 | $4,067 | $858.56 | 21.1% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Facility | 2022 | 13 | 13 | $1,924 | $430.56 | 22.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 33 | $5,396 | $1,978 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 16 | $5,992 | $1,458 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $8,064 | $1,113 | 13.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 19 | $2,877 | $654.47 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 22 | $3,353 | $1,329 | 39.6% |
About Dr. James Malone, MD
Dr. James Malone, MD is a Hematology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457343113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Malone, MD has received a total of $679.53 in payments from pharmaceutical and medical device companies, with $29.30 received in 2024. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($433.63).
As a Medicare-enrolled provider, Malone has provided services to 229 Medicare beneficiaries, totaling 314 services with total Medicare billing of $17,647. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Stanford, CA
- Active Since 08/18/2005
- Last Updated 04/12/2024
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1457343113
Products in Payments
- Soliris (Drug) $150.00
- QULIPTA (Drug) $114.57
- SOLIRIS (Drug) $101.45
- Imbruvica (Drug) $85.00
- SYNCHROMEDII (Device) $29.30
- IMBRUVICA (Drug) $26.41
- PADCEV (Drug) $26.37
- XTANDI (Drug) $25.35
- CREON (Drug) $16.27
- DARZALEX (Biological) $15.21
- UBRELVY (Drug) $14.92
- GAZYVA (Biological) $13.07
- BRAFTOVI (Drug) $12.56
- XALKORI (Drug) $11.61
- INLYTA (Drug) $11.30
- BESPONSA (Drug) $10.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Stanford
Saad Munib Ahmed Khan, Md, MD
Hematology — Payments: $315,298
Hematology $315,298
Michaela Liedtke, Md, MD
Hematology — Payments: $197,740
Hematology $197,740
Surbhi Sidana, M.d, M.D
Hematology — Payments: $111,114
Hematology $111,114
Robert Negrin, M.d, M.D
Hematology — Payments: $56,100
Hematology $56,100
Ravindra Majeti, M.d, M.D
Hematology — Payments: $54,202
Hematology $54,202
Robert Ohgami, M.d., Ph.d, M.D., PH.D
Hematology — Payments: $16,248
Hematology $16,248